Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1984 Apr;115(1):92–101.

Guinea pig plasma kallikrein as a vascular permeability enhancement factor. Its dependence on kinin generation and regulation mechanisms in vivo.

T Imamura, T Yamamoto, T Kambara
PMCID: PMC1900362  PMID: 6424481

Abstract

Plasma kallikrein (mol wt 80,000) was purified from guinea pig plasma, and it caused vascular permeability enhancement when injected into guinea pig skin. The activity had a linear relationship to the logarithm of kallikrein concentrations from 5 X 10(-9) M to 5 X 10(-6) M and was blocked by immunopurified anti-prekallikrein F(ab')2 rabbit antibody and soybean trypsin inhibitor. Carboxypeptidase B(1.7 units), a kinin-destructive enzyme, decreased the permeability activity to 1/20, while SQ 20,881 (10(-6) M), an inhibitor to a kinin-destructive enzyme, augmented the activity 5.4-fold. These results suggested that the permeability activity of kallikrein was performed finally through kinin generation in the skin. The permeability activity was short-lasting, and was completely blocked by a kallikrein inhibitor purified from guinea pig plasma, suggesting the presence of a down-regulation system for the permeability activity in vivo. Prostaglandin E2 (25 ng), a hyperemia inducer in microcirculation, augmented the permeability activity 12-fold, suggesting the presence of an up-regulation system in vivo. Accordingly, it was assumed that kallikrein-kinin system might play a role as a vascular permeability enhancement system in guinea pig skin.

Full text

PDF
92

Images in this article

95Figure 1
on p.95
96Figure 2
on p.96
99Figure 9
on p.99

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chao J., Buse J., Shimamoto K., Margolius H. S. Kallikrein-induced uterine contraction independent of kinin formation. Proc Natl Acad Sci U S A. 1981 Oct;78(10):6154–6157. doi: 10.1073/pnas.78.10.6154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cochrane C. G., Griffin J. H. Molecular assembly in the contact phase of the Hageman factor system. Am J Med. 1979 Oct;67(4):657–664. doi: 10.1016/0002-9343(79)90253-5. [DOI] [PubMed] [Google Scholar]
  3. Curd J. G., Prograis L. J., Jr, Cochrane C. G. Detection of active kallikrein in induced blister fluids of hereditary angioedema patients. J Exp Med. 1980 Sep 1;152(3):742–747. doi: 10.1084/jem.152.3.742. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. DAVIS B. J. DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS. Ann N Y Acad Sci. 1964 Dec 28;121:404–427. doi: 10.1111/j.1749-6632.1964.tb14213.x. [DOI] [PubMed] [Google Scholar]
  5. Davie E. W., Fujikawa K. Basic mechanisms in blood coagulation. Annu Rev Biochem. 1975;44:799–829. doi: 10.1146/annurev.bi.44.070175.004055. [DOI] [PubMed] [Google Scholar]
  6. Johnston M. G., Hay J. B., Movat H. Z. The modulation of enhanced vascular permeability by prostaglandins through alterations in blood flow (hyperemia). Agents Actions. 1976 Nov;6(6):705–711. doi: 10.1007/BF02026092. [DOI] [PubMed] [Google Scholar]
  7. Kaplan A. P., Meier H. L., Mandle R., Jr The Hageman factor dependent pathways of coagulation, fibrinolysis, and kinin-generation. Semin Thromb Hemost. 1976 Jul;3(1):1–26. doi: 10.1055/s-0028-1087162. [DOI] [PubMed] [Google Scholar]
  8. Kato H. [Initiation mechanism of intrinsic blood coagulation: activation of factor XII and roles of high-molecular-weight kininogen (author's transl)]. Seikagaku. 1980 Nov;52(11):1173–1200. [PubMed] [Google Scholar]
  9. Katori M., Ikeda K., Harada Y., Uchida Y., Tanaka K., Oh-Ishi S. A possible role of prostaglandins and bradykinin as a trigger of exudation in carrageenin-induced rat pleurisy. Agents Actions. 1978 Jan;8(1-2):108–112. doi: 10.1007/BF01972411. [DOI] [PubMed] [Google Scholar]
  10. Kerbiriou D. M., Griffin J. H. Human high molecular weight kininogen. Studies of structure-function relationships and of proteolysis of the molecule occurring during contact activation of plasma. J Biol Chem. 1979 Dec 10;254(23):12020–12027. [PubMed] [Google Scholar]
  11. Kozono K., Yamamoto T., Kambara T. A proteaselike permeability factor in guinea pig skin: contact activation of the latent permeability factor and its nature as a prekallikrein activator. Am J Pathol. 1980 Sep;100(3):619–632. [PMC free article] [PubMed] [Google Scholar]
  12. OUCHTERLONY O. Diffusion-in-gel methods for immunological analysis. Prog Allergy. 1958;5:1–78. [PubMed] [Google Scholar]
  13. Thompson R. E., Mandle R., Jr, Kaplan A. P. Characterization of human high molecular weight kininogen. Procoagulant activity associated with the light chain of kinin-free high molecular weight kininogen. J Exp Med. 1978 Feb 1;147(2):488–499. doi: 10.1084/jem.147.2.488. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Udaka K., Takeuchi Y., Movat H. Z. Simple method for quantitation of enhanced vascular permeability. Proc Soc Exp Biol Med. 1970 Apr;133(4):1384–1387. doi: 10.3181/00379727-133-34695. [DOI] [PubMed] [Google Scholar]
  15. Weber K., Osborn M. The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis. J Biol Chem. 1969 Aug 25;244(16):4406–4412. [PubMed] [Google Scholar]
  16. Williams T. J., Jose P. J. Mediation of increased vascular permeability after complement activation. Histamine-independent action of rabbit C5a. J Exp Med. 1981 Jan 1;153(1):136–153. doi: 10.1084/jem.153.1.136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Williams T. J., Morley J. Prostaglandins as potentiators of increased vascular permeability in inflammation. Nature. 1973 Nov 23;246(5430):215–217. doi: 10.1038/246215a0. [DOI] [PubMed] [Google Scholar]
  18. Williams T. J., Peck M. J. Role of prostaglandin-mediated vasodilatation in inflammation. Nature. 1977 Dec 8;270(5637):530–532. doi: 10.1038/270530a0. [DOI] [PubMed] [Google Scholar]
  19. Yamamoto T., Cochrane C. G. A protease-like permeability factor in guinea pig skin: immunologic identity with plasma Hageman factor. Am J Pathol. 1982 May;107(2):127–134. [PMC free article] [PubMed] [Google Scholar]
  20. Yamamoto T., Cochrane C. G. Guinea pig Hageman factor as a vascular permeability enhancement factor. Am J Pathol. 1981 Nov;105(2):164–175. [PMC free article] [PubMed] [Google Scholar]
  21. Yamamoto T., Kozono K., Okamoto T., Kato H., Kambara T. Purification of guinea-pig plasma prekallikrein. Activation by prekallikrein activator derived from guinea-pig skin. Biochim Biophys Acta. 1980 Aug 7;614(2):511–525. doi: 10.1016/0005-2744(80)90240-5. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES